FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892910101> ?p ?o ?g. }

• W2892910101 endingPage "e0204947" @default.
• W2892910101 startingPage "e0204947" @default.
• W2892910101 abstract "Kaposi’s sarcoma-associated herpesvirus (KSHV) is a cancer-causing virus in humans, primarily affecting AIDS patients. KSHV causes a range of cancers including Kaposi’s sarcoma, pleural effusion lymphoma and multicentric Castleman’s disease. Current methods available for treating these cancers are relatively ineffective, and new targets for therapy are needed. The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood. Here, a novel animal model was used to study how vIL-6 affects tumor development. Highly immune-deficient Rag2-/-γc-/- mice were transplanted with an immortalized human B cell line (BJAB) harboring either wild-type (WT) KSHV or a mutant strain lacking vIL-6 ΔvIL-6). Solid tumors developed and total tumor mass and the number of tumors were characterized. The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present. Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of vIL-6. B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6. The only marker that significantly increased in expression during tumor development was CD30. Tumor blood vessels were quantified to determine if more angiogenesis occurred with vIL-6-expressing virus, but there was no significant difference. These data indicate that vIL-6 plays a role in KSHV tumor formation in B cells in vivo. Further investigation into how vIL-6 manipulates CD30 expression may shed insight into KSHV oncogenesis, and may identify how vIL-6 can be targeted." @default.
• W2892910101 created "2018-10-05" @default.
• W2892910101 creator A5004946854 @default.
• W2892910101 creator A5022048896 @default.
• W2892910101 creator A5022414820 @default.
• W2892910101 creator A5026215667 @default.
• W2892910101 creator A5036700795 @default.
• W2892910101 creator A5070951418 @default.
• W2892910101 creator A5075625757 @default.
• W2892910101 creator A5083872386 @default.
• W2892910101 creator A5084744306 @default.
• W2892910101 date "2018-09-28" @default.
• W2892910101 modified "2023-09-27" @default.
• W2892910101 title "The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model" @default.
• W2892910101 cites W1491380704 @default.
• W2892910101 cites W1967278331 @default.
• W2892910101 cites W1973666901 @default.
• W2892910101 cites W1974338288 @default.
• W2892910101 cites W1975804534 @default.
• W2892910101 cites W2032438721 @default.
• W2892910101 cites W2033898924 @default.
• W2892910101 cites W2037290021 @default.
• W2892910101 cites W2037614257 @default.
• W2892910101 cites W2045188113 @default.
• W2892910101 cites W2049775946 @default.
• W2892910101 cites W2060235886 @default.
• W2892910101 cites W2063754496 @default.
• W2892910101 cites W2072843113 @default.
• W2892910101 cites W2074829227 @default.
• W2892910101 cites W2084994078 @default.
• W2892910101 cites W2091719796 @default.
• W2892910101 cites W2114512831 @default.
• W2892910101 cites W2116356638 @default.
• W2892910101 cites W2121556311 @default.
• W2892910101 cites W2133064188 @default.
• W2892910101 cites W2150278751 @default.
• W2892910101 cites W2158849686 @default.
• W2892910101 cites W2160508776 @default.
• W2892910101 cites W2166187451 @default.
• W2892910101 cites W2194246005 @default.
• W2892910101 cites W2261829141 @default.
• W2892910101 cites W263231553 @default.
• W2892910101 cites W3112188057 @default.
• W2892910101 cites W41704597 @default.
• W2892910101 doi "https://doi.org/10.1371/journal.pone.0204947" @default.
• W2892910101 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6161906" @default.
• W2892910101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30265712" @default.
• W2892910101 hasPublicationYear "2018" @default.
• W2892910101 type Work @default.
• W2892910101 sameAs 2892910101 @default.
• W2892910101 citedByCount "4" @default.
• W2892910101 countsByYear W28929101012020 @default.
• W2892910101 countsByYear W28929101012021 @default.
• W2892910101 countsByYear W28929101012023 @default.
• W2892910101 crossrefType "journal-article" @default.
• W2892910101 hasAuthorship W2892910101A5004946854 @default.
• W2892910101 hasAuthorship W2892910101A5022048896 @default.
• W2892910101 hasAuthorship W2892910101A5022414820 @default.
• W2892910101 hasAuthorship W2892910101A5026215667 @default.
• W2892910101 hasAuthorship W2892910101A5036700795 @default.
• W2892910101 hasAuthorship W2892910101A5070951418 @default.
• W2892910101 hasAuthorship W2892910101A5075625757 @default.
• W2892910101 hasAuthorship W2892910101A5083872386 @default.
• W2892910101 hasAuthorship W2892910101A5084744306 @default.
• W2892910101 hasBestOaLocation W28929101011 @default.
• W2892910101 hasConcept C121608353 @default.
• W2892910101 hasConcept C142724271 @default.
• W2892910101 hasConcept C203014093 @default.
• W2892910101 hasConcept C2776107976 @default.
• W2892910101 hasConcept C2778256501 @default.
• W2892910101 hasConcept C2779013556 @default.
• W2892910101 hasConcept C2779338263 @default.
• W2892910101 hasConcept C2779594685 @default.
• W2892910101 hasConcept C3020616263 @default.
• W2892910101 hasConcept C502942594 @default.
• W2892910101 hasConcept C54355233 @default.
• W2892910101 hasConcept C555283112 @default.
• W2892910101 hasConcept C70905583 @default.
• W2892910101 hasConcept C71924100 @default.
• W2892910101 hasConcept C86803240 @default.
• W2892910101 hasConceptScore W2892910101C121608353 @default.
• W2892910101 hasConceptScore W2892910101C142724271 @default.
• W2892910101 hasConceptScore W2892910101C203014093 @default.
• W2892910101 hasConceptScore W2892910101C2776107976 @default.
• W2892910101 hasConceptScore W2892910101C2778256501 @default.
• W2892910101 hasConceptScore W2892910101C2779013556 @default.
• W2892910101 hasConceptScore W2892910101C2779338263 @default.
• W2892910101 hasConceptScore W2892910101C2779594685 @default.
• W2892910101 hasConceptScore W2892910101C3020616263 @default.
• W2892910101 hasConceptScore W2892910101C502942594 @default.
• W2892910101 hasConceptScore W2892910101C54355233 @default.
• W2892910101 hasConceptScore W2892910101C555283112 @default.
• W2892910101 hasConceptScore W2892910101C70905583 @default.
• W2892910101 hasConceptScore W2892910101C71924100 @default.
• W2892910101 hasConceptScore W2892910101C86803240 @default.
• W2892910101 hasIssue "9" @default.
• W2892910101 hasLocation W28929101011 @default.
• W2892910101 hasLocation W28929101012 @default.

• next